Bio-Path Holdings, Inc.
BPTH
$0.03
-$0.01-19.53%
OTC PK
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 531.71% | -80.75% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 624.39% | -91.60% | |||
| Operating Income | -624.39% | 91.60% | |||
| Income Before Tax | -8.43% | 74.49% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -8.43% | 74.49% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -8.43% | 74.49% | |||
| EBIT | -624.39% | 91.60% | |||
| EBITDA | -610.49% | 91.44% | |||
| EPS Basic | 8.25% | 72.49% | |||
| Normalized Basic EPS | -12.27% | 77.23% | |||
| EPS Diluted | 8.25% | 72.49% | |||
| Normalized Diluted EPS | -12.27% | 77.23% | |||
| Average Basic Shares Outstanding | 18.16% | -7.22% | |||
| Average Diluted Shares Outstanding | 18.16% | -7.22% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||